Vaxxinity's Cholesterol Vaccine Candidate Successfully Lower

Vaxxinity's Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published -February 15, 2024 at 08:02 am EST

Preclinical data published in the Journal of Lipid Research indicate VXX-401 is well-tolerated, with no safety signals observed, and robustly reduces LDL-C in cynomolgus monkeys. A Phase 1 trial of...

Related Keywords

Mark Joinnides , Jon Yu , Vaxxinity Inc , Exchange Commission On , World Health Organization , Journal Of Lipid Research Volume , Journal Of Lipid Research , Nasdaq , Lipid Research , Private Securities Litigation Reform Act , Annual Report , Exchange Commission , World Health , Clinical Outcomes , Cardiovascular Outcomes , Acute Coronary , Markets ,